InvestorNewsBreak – Progressive Care Inc.’s (RXMD) PharmcoRx Collaborates to Expand Medicare Advantage OTC Benefits

Progressive Care (OTCQB: RXMD), a personalized health care services and technology provider, today announced that its PharmcoRx pharmacy subsidiary entered an agreement with ProHealth Connect LLC, aiming to extend over-the-counter product (“OTC”) benefits provided by health insurance plans to qualifying members nationwide. Under the partnership, the OTC benefits offered by Medicare Advantage (“MA”) plans such as United, Humana, Devoted, Sharecare, and more, enabling their members to purchase OTC health care products and medicines using their plan benefits, are now accepted at all PharmcoRx pharmacies. “We are thrilled to further expand the access to valuable OTC benefits for our pharmacy customers, enabling them to purchase their over-the-counter products and medications from us when they have their prescriptions filled,” said Dr. Pamela Roberts, chief operating officer of Progressive Care. “Through our participation in these valuable OTC benefit programs, we have the potential to expand awareness of PharmcoRx pharmacies and further serve the needs of millions of Medicare Advantage members as part of our ongoing commitment to community-centric services.”

To view the full press release, visit https://ibn.fm/vfCnV

About Progressive Care Inc.

Progressive Care, through its subsidiaries, is a Florida health services organization and provider of third-party administration (“TPA”), data management, COVID-19-related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (“MTM”), the supply of prescription medications to long-term care facilities, and health practice risk management. Progressive Care became a subsidiary of NextPlat Corp.(NASDAQ: NXPL, NXPLW) on July 1, 2023.

NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at https://ibn.fm/RXMD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.